Gamida Cell Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$2.0M
Doctors Paid
36
Transactions
132
2024 Total
$824,454
Payment Breakdown by Category
Research$1.7M (88.5%)
Consulting$223,769 (11.4%)
Food & Beverage$2,229 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.7M | 76 | 88.5% |
| Consulting Fee | $223,769 | 25 | 11.4% |
| Food and Beverage | $2,229 | 31 | 0.1% |
Payments by Type
Research
$1.7M
76 transactions
General
$225,998
56 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| EVALUATION OF SAFETY AND EFFICACY OF ALLO GDA-201 NK CELLS IN PATIENTS WITH RELAPSED REFRACTORY B CELL NHL | $583,470 | 0 | 17 |
| EVALUATION OF SAFETY AND EFFICACY OF ALLO GDA-201 CELLS IN PATIENTS WITH RELAPSED/REFRACTORY B CELL NHL | $445,551 | 0 | 20 |
| STEM CELL TRANSPLANTATION WITH NICORD (OMIDUBICEL) VS STANDARD UCB IN PATIENTS WITH LEUKEMIA, LYMPHOMA, AND MDS | $429,659 | 0 | 17 |
| EXPANDED ACCESS OF OMIDUBICEL, FOR ALLOGENEIC TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES | $248,458 | 0 | 18 |
| LONG TERM FOLLOW UP PROTOCOL FOR NICORD\CORDIN (OMIDUBICEL) PATIENTS | $33,726 | 0 | 4 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Medical Oncology | $182,619 | 1 | $182,619 |
| Hematology & Oncology | $27,273 | 15 | $1,818 |
| Internal Medicine | $6,204 | 9 | $689.28 |
| Hematology | $6,093 | 2 | $3,047 |
| Pediatric Hematology-Oncology | $1,697 | 2 | $848.44 |
| Pediatrics | $1,650 | 1 | $1,650 |
| Student in an Organized Health Care Education/Training Program | $129.30 | 3 | $43.10 |
| Clinical Nurse Specialist | $112.18 | 1 | $112.18 |
| Physician Assistant | $112.18 | 1 | $112.18 |
| Family | $109.31 | 1 | $109.31 |
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Anand Srinivasan, M D, M D | Pediatric Hematology-Oncology | Rochester, MN | $46.87 | $0 |
| Dr. Ioannis Politikos, M.d, M.D | Internal Medicine | New York, NY | $45.58 | $0 |
| Dr. Nikhita Kathuria-Prakash, Md, MD | Hematology | Lake City, FL | $43.10 | $0 |
| Jonathan Boiarsky | Student in an Organized Health Care Education/Training Program | Los Angeles, CA | $43.10 | $0 |
| Rui Li | Student in an Organized Health Care Education/Training Program | Los Angeles, CA | $43.10 | $0 |
| Georgia Lill | Internal Medicine | Los Angeles, CA | $43.10 | $0 |
| Dr. Eileen Shiuan, Md, Phd, MD, PHD | Student in an Organized Health Care Education/Training Program | Los Angeles, CA | $43.10 | $0 |
| Gary Schiller, Md, MD | Hematology & Oncology | Los Angeles, CA | $43.10 | $0 |
| Renju Vechurettu Raj, M.d, M.D | Internal Medicine | Milwaukee, WI | $30.15 | $0 |
| Nebu Koshy, M.d, M.D | Hematology & Oncology | Dallas, TX | $30.15 | $0 |
| Usama Gergis, Md, MD | Hematology & Oncology | Allentown, PA | $26.78 | $0 |
About Gamida Cell Inc.
Gamida Cell Inc. has made $2.0M in payments to 36 healthcare providers, recorded across 132 transactions in the CMS Open Payments database. In 2024, the company paid $824,454. The top product by payment volume is OMISIRGE ($937,842).
Payments were distributed across 10 medical specialties. The top specialty by payment amount is Medical Oncology ($182,619 to 1 doctors).
Payment categories include: Food & Beverage ($2,229), Consulting ($223,769), Research ($1.7M).
Gamida Cell Inc. is associated with 1 products in the CMS Open Payments database.